Loading clinical trials...
Loading clinical trials...
This is a drug interaction study in HIV negative, TB-monoinfected participants coming to the end of continuation phase of TB therapy, to study the pharmacokinetic changes to dolutegravir when administ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Helen Reynolds
Collaborators
NCT07466836 · Human Immunodeficiency Virus (HIV)
NCT04923958 · Tuberculosis
NCT06590428 · Rifampin-resistant Tuberculosis, Drug-resistant Tuberculosis
NCT06784908 · HIV, Depression, and more
NCT01875588 · HIV Positive
Desmond Tutu Health Foundation
Cape Town
Infectious Diseases Institute
Kampala
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions